Detection and Imaging of Active Substances in Early Atherosclerotic Lesions Using Fluorescent Probes. 2023

Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for, Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Institute of Biomedical Sciences, Shandong Normal University, Jinan, 250014, P. R. China.

Atherosclerosis (AS) is a vascular disease caused by chronic inflammation and lipids that is the main cause of myocardial infarction, stroke and other cardiovascular diseases. Atherosclerosis is often difficult to detect in its early stages due to the absence of clinically significant vascular stenosis. This is not conducive to early intervention or treatment of the disease. Over the past decade, researchers have developed various imaging methods for the detection and imaging of atherosclerosis. At the same time, more and more biomarkers are being found that can be used as targets for detecting atherosclerosis. Therefore, the development of a variety of imaging methods and a variety of targeted imaging probes is an important project to achieve early assessment and treatment of atherosclerosis. This paper provides a comprehensive review of the optical probes used to detect and target atherosclerosis imaging in recent years, and describes the current challenges and future development directions.

UI MeSH Term Description Entries
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D057054 Molecular Imaging The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; FLUORESCENCE IMAGING; and MICROSCOPY. Imaging, Molecular
D058226 Plaque, Atherosclerotic Lesions formed within the walls of ARTERIES associated with deposits of fat and other substances that accumulate in the lining of the artery wall. Atheromatous Plaque,Atheroma,Atheromatous Plaques,Atherosclerotic Plaque,Atherosclerotic Plaques,Fatty Streak, Arterial,Fibroatheroma,Fibroatheromatous Plaques,Arterial Fatty Streak,Arterial Fatty Streaks,Atheromas,Fibroatheromas,Fibroatheromatous Plaque,Plaque, Atheromatous,Plaque, Fibroatheromatous,Streak, Arterial Fatty

Related Publications

Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
February 2012, Journal of the American College of Cardiology,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
January 2016, Methods in molecular biology (Clifton, N.J.),
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
January 2015, Methods in molecular biology (Clifton, N.J.),
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
January 1984, Atherosclerosis,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
December 2009, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
June 2015, Biosensors,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
December 2019, Journal of veterinary research,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
January 2021, Analytical biochemistry,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
April 2020, Analytical biochemistry,
Jin Li, and Jiheng Xu, and Wei Zhang, and Ping Li, and Wen Zhang, and Hui Wang, and Bo Tang
February 2022, Chemical communications (Cambridge, England),
Copied contents to your clipboard!